Patrick Soon-Shiong

$6.29B

as of 07/05/24

About Patrick Soon-Shiong

Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.

He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.

He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.

He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.

He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.

In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.

Personal stats

Citizenship

United States of America

Source of wealth

Pharmaceuticals

Residence

Los Angeles, California

Marital status

Married

Birth date

07/29/52 (age 71)

Number of children

Education

Master of Science, University of British Columbia; Bachelor of Arts/Science, University of Witwatersrand; Medical Doctor, University of Witwatersrand

Self-made

self-made